Funder: U.S. Food and Drug Administration (FDA)

The purpose of this funding opportunity announcement (FOA) is to fund innovative research that will strengthen and advance COVID-19 health equity research.

Areas of interest include:

Proposals that focus on advancing racial and ethnic minority participation in COVID-19/COVID-19 variant clinical trials and/or contribute to informing the continued evaluation of the safety and efficacy of FDA approved products (therapeutics, diagnostics, and vaccines) or products subject to EUAs/EUA expansion for the treatment, prevention, or diagnosis of COVID-19. 

Proposals that support the evaluation of outcomes by demographic data including, but not limited to, ethnicity, race, age, disability, and geography.

Proposals that support COVID-19 research to understand diverse patient perspectives, preferences, and unmet needs

Topics: Clinical Trial, Community Engagement, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Mobile Health, App, Telemedicine, Wearables, Oral Science / Dentistry, Prevention, PPE, Social Distancing, Research Site, Community-based, Social Determinants of Health, Target Population, Children, Deaf Persons, Elderly, Homeless Persons, Pregnant Women, Prisoners, Teens, Treatments, Vaccines, Vaccine Hesitancy